Podium Power

Epi-on CXL aims to sidestep epi-off CXL’s issues by leaving the epithelium intact, however, this comes at a price of reduced efficacy – no clinical trial published to date has convincingly shown epi-on CXL to be as effective as epi-off CXL at the most important outcome: stopping keratoconus from progressing.
Being appointed FARVO – Fellow of the Association for Research in Vision and Ophthalmology – is a big deal for me. Let me tell you why…
The Cross-Linking Experts 2018 Meeting 2018 Zurich, organised by the Light for Sight Foundation,  took place in Zurich for the 14th consecutive time
Swiss ophthalmologist receives an award in Russia: The ophthalmologist Farhad Hafezi from the ELZA Institute gave the honorary lecture at the renowned Fyodorov Microsurgery Eye Institute in Moscow
Farhad Hafezi was interviewed by Eyetube on the K-MAP keratoconus prevalence study at ESCRS 2018.
The ELZA Institute’s surgeons and researchers spent four days in Vienna at the 36th Congress of the ESCRS, and went to the meeting with a busy schedule!
Why did the Serbian military offer to fly Prof. Farhad Hafezi in a helicopter to a ski resort in early September? After all, the slopes were green with grass, not white with snow.
.
.